Clinical Trial Update: Safety Profile of Psilocybin for Cocaine Use Disorder [EARLY_Phase 1]

View source ↗

Summary

This update reports on the safety profile of psilocybin in an early-phase trial for cocaine use disorder. The study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine Use Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cocaine Use Disorder | EARLY_Phase 1 | Status: SUSPENDED